Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) FCF Margin (2017 - 2025)

Selectis Health's FCF Margin history spans 14 years, with the latest figure at 2.54% for Q3 2025.

  • For Q3 2025, FCF Margin rose 1479.0% year-over-year to 2.54%; the TTM value through Sep 2025 reached 1.05%, up 962.0%, while the annual FY2024 figure was 4.65%, 603.0% down from the prior year.
  • FCF Margin for Q3 2025 was 2.54% at Selectis Health, up from 2.31% in the prior quarter.
  • Across five years, FCF Margin topped out at 26.23% in Q3 2023 and bottomed at 20.17% in Q4 2023.
  • The 5-year median for FCF Margin is 2.31% (2025), against an average of 1.65%.
  • The largest annual shift saw FCF Margin crashed -4032bps in 2021 before it soared 3658bps in 2023.
  • A 5-year view of FCF Margin shows it stood at 12.83% in 2021, then tumbled by -67bps to 4.2% in 2022, then crashed by -580bps to 20.17% in 2023, then skyrocketed by 81bps to 3.93% in 2024, then soared by 165bps to 2.54% in 2025.
  • Per Business Quant, the three most recent readings for GBCS's FCF Margin are 2.54% (Q3 2025), 2.31% (Q2 2025), and 7.78% (Q1 2025).